Pharma major Cadila Healthcare Ltd plans to invest Rs 40 crore (Rs 400 million) to acquire stake in a Europe-based biotech company.
The board of directors at a meeting held on Aug 27 approved in principle an investment in equity of up to Rs 40 crore in an European biotech company, Cadila informed the Bombay Stock Exchange.
The decision is subject to satisfactory due diligence to be carried out by the company, it said.
© Copyright 2025 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
